PUBPOL 5110

Pharmaceutical Management and Policy

Course Description

Course information provided by the 2024-2025 Catalog. Courses of Study 2024-2025 is scheduled to publish mid-June.

This course provides an overview of management and policy issues facing the pharmaceutical industry.  The course begins with the US market, which is the largest and most profitable, and then explores the state of the industry in other high-income countries as well as emerging markets and developing nations. We also explore the actions of the pharmaceutical industry in the COVID-19 pandemic.

Forbidden Overlaps Forbidden Overlap: due to overlap in content, students will not receive credit for both PUBPOL 5110 and PUBPOL 5900; (Topic "Key Mgmt Issues-Pharmaceutical & Biotech Industry").

Last 4 Terms Offered (None)

Outcomes

• Describe the objectives and behavior of each of the major stakeholders in the pharmaceutical industry.
• Assess the benefits and drawbacks of various policies to improve the efficiency and effectiveness of the pharmaceutical industry.
• Take advantage of publicly-available data in a self-directed investigation into a prescription drug.

When Offered Spring.

View Enrollment Information